PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging misleading advertising claims related to GLP-1 medications.

21 Jul, 13:50 — 21 Jul, 13:50
PostShare

Sources

Showing 1 of 1 sources